Is there a preferable DES in diabetic pa
β
Robert A. Byrne; Adnan Kastrati
π
Article
π
2008
π
John Wiley and Sons
π
English
β 82 KB
π 2 views
## Abstract Drugβeluting stent (DES) therapy reduces restenosis in patients with diabetes when compared with bare metal stent implantation. There are significant differences between commercially available DES platforms both in terms of design characteristics and clinical outcomes. Randomized active